J. Imperio

Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model

J. Elstrott, Z. Modrušan, K. Stark, 2020, The Journal of Neuroscience.

Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology

Melanie A. Huntley, K. Stark, Christopher J. Bohlen, 2021, Neuron.

Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.

J. Lubach, H. Wong, Lichuan Liu, 2013, Molecular pharmaceutics.

The distribution patterns of biatrial myxomas.

N. Krasnow, V. Piccone, J. Imperio, 1980, Annals of Thoracic Surgery.

Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ

J. Ernst, J. Atwal, Janice A. Maloney, 2019, Alzheimer's Research & Therapy.

Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer's Disease.

Jianping Yin, Xingrong Liu, J. Lyssikatos, 2017, Journal of medicinal chemistry.

Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALS

M. Hedehus, J. Eastham‐Anderson, D. Kirkpatrick, 2019, Neurobiology of Disease.

Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS

K. Stark, J. Webster, O. Foreman, 2020, Cell Death & Differentiation.